secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beta Bionics, Inc. (BBNX)
CIK:        0001674632
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001171843-25-001785
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beta Bionics appoints Gerard Michel as Class III director
---------------------------------------------------------

- Gerard Michel appointed to board effective March 26, 2025; term expires at 2028 annual meeting.
- Michel currently CEO of Delcath Systems; former CFO of Vericel, Biodel, and NPS Pharmaceuticals.
- Annual cash retainer of $50,000; initial RSU grant of 12,547 shares vesting on one-year anniversary.
- No material arrangements or transactions with Michel requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674632/000117184325001785/0001171843-25-001785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674632/000117184325001785/f8k_032725.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer